Chyloperitoneum in Peritoneal Dialysis Secondary to Calcium Channel Blocker Use: Case Series and Literature Review.
PD complication
calcium channel blocker
chyloperitoneum
chylous ascites
effluent
peritoneal dialysis
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
01 Mar 2023
01 Mar 2023
Historique:
received:
29
01
2023
revised:
22
02
2023
accepted:
27
02
2023
entrez:
11
3
2023
pubmed:
12
3
2023
medline:
12
3
2023
Statut:
epublish
Résumé
Chyloperitoneum (chylous ascites) is a rare complication of peritoneal dialysis (PD). Its causes may be traumatic and nontraumatic, associated with neoplastic disease, autoimmune disease, retroperitoneal fibrosis, or rarely calcium antagonist use. We describe six cases of chyloperitoneum occurring in patients on PD as a sequel to calcium channel blocker use. The dialysis modality was automated PD (two patients) and continuous ambulatory PD (the rest of the patients). The duration of PD ranged from a few days to 8 years. All patients had a cloudy peritoneal dialysate, characterized by a negative leukocyte count and sterile culture tests for common germs and fungi. Except for in one case, the cloudy peritoneal dialysate appeared shortly after the initiation of calcium channel blockers (manidipine,
Identifiants
pubmed: 36902718
pii: jcm12051930
doi: 10.3390/jcm12051930
pmc: PMC10003695
pii:
doi:
Types de publication
Case Reports
Langues
eng
Références
Blood Purif. 1989;7(6):309-13
pubmed: 2611001
Semin Dial. 2019 Jan;32(1):72-79
pubmed: 30032485
N Engl J Med. 2021 Nov 4;385(19):1786-1795
pubmed: 34731538
Cardiovasc Res. 2022 Aug 24;118(11):2437-2457
pubmed: 34415332
Microvasc Res. 1983 Jan;25(1):22-39
pubmed: 6835097
J Nephrol. 2021 Jun;34(3):913-914
pubmed: 33683677
Semin Cell Dev Biol. 2015 Feb;38:55-66
pubmed: 25617600
Perit Dial Int. 2012 Jan-Feb;32(1):110-1
pubmed: 22302929
J Clin Pharm Ther. 2017 Oct;42(5):638-641
pubmed: 28485829
Perit Dial Int. 1992;12(3):287-91
pubmed: 1511045
Am J Kidney Dis. 2003 Dec;42(6):1260-9
pubmed: 14655199
J Physiol. 2010 Jan 1;588(Pt 1):243-54
pubmed: 19917564
Clin Nephrol. 2010 Sep;74(3):217-22
pubmed: 20860906
Ther Apher Dial. 2022 Aug;26(4):852-853
pubmed: 34859589
J Physiol. 2016 Oct 15;594(20):5749-5768
pubmed: 27219461
Nefrologia. 2014;34(5):683-5
pubmed: 25259826
Front Pharmacol. 2022 Mar 09;13:848088
pubmed: 35355722
Nefrologia. 2013;33(3):377-80
pubmed: 23712225
Kidney Int. 2009 Apr;75(8):868
pubmed: 19337227
Nephrology (Carlton). 2005 Aug;10(4):344-7
pubmed: 16109079
Nat Genet. 2005 Oct;37(10):1072-81
pubmed: 16170315
Adv Perit Dial. 1996;12:27-32
pubmed: 8865867
Annu Rev Cell Dev Biol. 2000;16:521-55
pubmed: 11031246
J Am Soc Nephrol. 2016 Nov;27(11):3238-3252
pubmed: 27339663
J Clin Med. 2019 Apr 05;8(4):
pubmed: 30959848
Am J Physiol Heart Circ Physiol. 2008 Nov;295(5):H1989-2000
pubmed: 18790842
Nefrologia. 2011;31(5):624
pubmed: 21959742
BMJ Case Rep. 2019 Aug 21;12(8):
pubmed: 31439572
G Ital Nefrol. 2018 Jul;35(4):
pubmed: 30035445
Curr Med Chem. 2021;28(3):514-524
pubmed: 32664834
J Physiol. 1993 Nov;471:465-79
pubmed: 8120817
Am J Physiol. 1986 May;250(5 Pt 2):H706-10
pubmed: 3706547
Lymphat Res Biol. 2007;5(1):29-43
pubmed: 17508900
Sci Rep. 2020 Jan 9;10(1):70
pubmed: 31919478
Aliment Pharmacol Ther. 2017 Nov;46(9):816-824
pubmed: 28892178
Perit Dial Int. 2008 Nov-Dec;28(6):632-6
pubmed: 18981394
J Physiol. 2014 Nov 1;592(21):4697-714
pubmed: 25172950
J Vis Exp. 2011 Dec 08;(58):
pubmed: 22214883
Front Pharmacol. 2017 May 29;8:286
pubmed: 28611661
Am J Physiol. 1980 Dec;239(6):H775-83
pubmed: 7446752
Nephrol Dial Transplant. 2017 Apr 1;32(4):620-640
pubmed: 28340239
Int J Environ Res Public Health. 2019 Apr 13;16(8):
pubmed: 31013922